Tag results:
lymphocytes
Immune Regulation News
RORÎłt Phosphorylation Protects against T Cell-Mediated Inflammation
[Cell Reports] Investigators reported that serine 182 phosphorylation was a major post-translational modification was not involved in thymic T cell development and effector T cell differentiation.
Immune Regulation News
Targeting the PSGL-1 Immune Checkpoint Promotes Immunity to PD-1 Resistant Melanoma
[Cancer Immunology Research] Using an aggressive melanoma tumor model, the authors targeted PSGL-1 in tumor-bearing mice and found increased effector CD4+ and CD8+ T cell responses and decreased regulatory T cells in tumors.
Immunology of Infectious Disease News
Antibody Decay, T Cell Immunity and Breakthrough Infections Following Two SARS-CoV-2 Vaccine Doses in Inflammatory Bowel Disease Patients Treated with Infliximab and Vedolizumab
[Nature Communications] The authors reported SARS-CoV-2 vaccine-induced immune responses and breakthrough infections in patients with inflammatory bowel disease, who were treated either with an anti-tumor necrosis factor antibody, infliximab, or with vedolizumab targeting a gut-specific anti-integrin that did not impair systemic immunity.
Immune Regulation News
Age-Associated Impairment of T Cell Immunity Is Linked to Sex-Dimorphic Elevation of N-Glycan Branching
[Nature Aging] The authors showed that branching of asparagine-linked glycans increased with age in females more than in males, in naive T cells more than in memory T cells, and in CD4+ more than in CD8+ T cells.
Immune Regulation News
In Situ Imaging for Tumor Microbiome Interactions via Imaging Mass Cytometry on Single-Cell Level
[Cytometry Part A] Researchers developed a rapid semi-quantitative method for in situ imaging of bacteria and multiplex cell phenotypes on the same solid tumor tissue sections.
Human Immunology News
Type I Interferon Transcriptional Network Regulates Expression of Coinhibitory Receptors in Human T Cells
[Nature Immunology] Researchers showed that type 1 interferon regulated coinhibitory receptor expression on human T cells, inducing PD-1/TIM-3/LAG-3 while inhibiting T cell immunoreceptor with immunoglobulin and ITIM domains expression.